Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Orenitram (treprostinil) for Treatment of Pulmonary Arterial Hypertension (PAH)

Drug Name (Brand / Generic)

Orenitram / treprostinil / UT-15C

Company / Licensee

United Therapeutics Corporation / Supernus Pharmaceuticals

Therapy Class

Prostacyclin analogue

Current Indication

Pulmonary arterial hypertension (PAH)

Market Sector

Cardiovascular

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top